1,3-phenylenediamine

We are 1,3-phenylenediamine CAS:108-45-2 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:1,3-phenylenediamine
CAS.NO:108-45-2
Synonyms:Benzene-1,3-diamine 
meta-Phenylenediamine (MPD) 
m-Phenylenediamine
1,3-Benzenediamine
Molecular Formula:C6H8N2
Molecular Weight:108.14100
 
Physical and Chemical Properties:
Density:1.139;
Melting point:64-66oC;
Boiling point:282-284oC;
Flash point:230oF;
Index of Refraction:1.6339;
 
Specification:
Appearance:Light brown flake
Purity(HPLC):≥99.0%
Ash:≤1.0%
Loss on drying:≤0.5%
Fe content:≤100ppm
P-Phenylenediamine:≤0.05%
O-Phenylenediamine:≤0.2%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Hair dyes intermediate
 

1,3-phenylenediamine


Related News: In 2016, in order to promote the innovative development, transformation and upgrading of the pharmaceutical industry, the Development and Reform Commission led the compilation of the “Guiding Opinions on Promoting the Healthy Development of the Pharmaceutical Industry”, which put forward requirements for all aspects of the medical industry and specifically proposed support for the field of chemical raw materials. .327-56-0 However, in the long run, as the bulk API market continues to fall, more and more companies will transition to specialty API companies, and competition will intensify in the future.ethyl 4-(5-amino-1-methylbenzimidazol-2-yl)butanoate CAS:3543-73-5 In April 2019, Glenmark had received approval from the Drugs Controller General of India (DCGI) for Remogliflozin Etabonate after successfully completing Phase-3 clinical trials.1,4-Phenylene dipropionate Onconova Therapeutics, Inc. and Inceptua Medicines Access (a business unit of the Inceptua Group) recently announced they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.In the early stage of market development, API companies usually need to strive to become a supply company for pharmaceutical companies after quickly completing product preparations. In the subsequent scale-up of production and market application, the relationship between pharmaceutical companies and API companies will become closer. The choice of R & D products of pharmaceutical companies will also be affected by pharmaceutical companies in turn.

Related Products
Product Name
5-(Trifluoromethyl)pyridin-2-amine View Details
2,4-Dichlorobenzaldehyde View Details
Ethyl 6-bromohexanoate View Details
2-Bromo-4-trifluoromethoxyaniline manufacturer N,N-dimethyl-2-morpholin-4-ylethanamine manufacturer 2,6-Difluorophenol manufacturer 2-Bromo-2′-fluoroacetophenone manufacturer Butyryl chloride manufacturer